0.2502
price down icon32.58%   -0.1209
after-market Handel nachbörslich: .24 -0.0102 -4.08%
loading

Finanzdaten der Intensity Therapeutics Inc-Aktie (INTS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
20.30%
2.705
3.394 3.203 3.57 5.069
Operating Income/Loss
20.30%
-2.705
-3.394 -3.203 -3.57 -5.069
Income/Loss From Continuing Operations Before Tax
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Income/Loss From Continuing Operations After Tax
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Net Income/Loss
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
24.35%
18.87
15.17 0.1646 13.80 13.71
Diluted Average Shares
24.35%
18.87
15.17 0.1646 13.80 13.71
Basic Earnings Per Share
40.91%
-0.13
-0.22 -0.22 -0.25 -0.36
Diluted Earnings Per Share
40.91%
-0.13
-0.22 -0.22 -0.25 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$26.45
price down icon 1.12%
$45.19
price up icon 0.87%
$101.10
price up icon 0.35%
$105.87
price up icon 0.10%
$148.75
price up icon 1.77%
biotechnology ONC
$346.07
price down icon 0.10%
Kapitalisierung:     |  Volumen (24h):